Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel

Autor: Sessa, C., Tosi, D., Viganò, L., Albanell, J., Hess, D., Maur, M., Cresta, S., Locatelli, A., Angst, R., Rojo, F., Coceani, N., Rivera, V.M., Berk, L., Haluska, F., Gianni, L. *
Zdroj: In Annals of Oncology June 2010 21(6):1315-1322
Databáze: ScienceDirect